| Report ID | 278891 |
| Drug Identification Number | 02014300 |
| Brand name | MS CONTIN |
| Common or Proper name | Morphine Sulfate Sustained Release Tablets |
| Company Name | PURDUE PHARMA |
| Market Status | MARKETED |
| Active Ingredient(s) | MORPHINE SULFATE |
| Strength(s) | 60MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 60 |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2026-02-24 |
| Estimated end date | 2026-03-13 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-02-27 |
| Company comments | Under Quality investigation. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2026-02-27 | French | Compare |
| v3 | 2026-02-27 | English | Compare |
| v2 | 2026-02-24 | French | Compare |
| v1 | 2026-02-24 | English | Compare |
Showing 1 to 4 of 4